DUBLIN–(BUSINESS WIRE)–The “Cell Therapy Technology Market by Process, by Cell Type, by Product, by End User, and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The cell therapy technology market size is estimated to be USD 14,532.1 million in 2021 and is expected to witness a CAGR of 13.63% during the forecast period 2022-2029. The increasing cell-based therapies focused on treating cancer, technological development, significant government funding for cell-based research and product advancements are some of the key drivers for the market growth. However, high price of cell-based research, poor success rate, and the absence of an effective and efficient healthcare infrastructure are expected to restrain the market growth.
By Process
Based on process, the market is segmented into cell preservation, distribution, & handling, cell processing, and process monitoring & quality control. In 2021, the cell processing segment accounted for the largest revenue share owing to rising investments in the R&D of cell manufacturing technologies.
By Cell Type
On the basis of cell type, the market is categorized into stem cells, t-cells, and others. In the global market, the stem cells segment accounted for the largest revenue share in 2021 owing to the development of innovative treatments for chronic diseases and a large increase in the number of stem cell applications in clinical settings.
By Product
Based on product, the market is categorized into equipment, consumables, and systems & software. In 2021, the consumables accounted for the highest revenue share due to rising corporate investment in the development of cutting-edge technologies and government initiatives to enhance cell-based research.
By End User
On the basis of end user, the market is divided into research institutes and life science research companies. In 2021, the life science research companies segment accounted for the largest revenue share owing to significant adoption of cutting-edge tools in cell-based experiments and cancer research, and the rising number of research & development facilities worldwide.
Regional Markets In 2021, North America region accounted for the highest revenue in the cell therapy technology market and is expected to maintain its dominance during the forecast period. This is attributed to rising R&D efforts in the pharmaceutical and biotechnology industries and the increasing incidence of chronic diseases in this region. However, due to the rising research investment for vaccine development, Asia Pacific is anticipated to become the area with the most potential throughout the projection period.
Segmentation: Cell Therapy Technology Market Report 2021-2029Process (Revenue, USD Million)
- Cell Preservation, Distribution, & Handling
- Cell Processing
- Process Monitoring & Quality Control
Cell Type (Revenue, USD Million)
- Stem Cells
- T-cells
- Others
Product (Revenue, USD Million)
- Equipment
- Consumables
- Systems & Software
End user (Revenue, USD Million)
- Research Institutes
- Life Science Research Companies
By Region (Revenue, USD Million)
North America
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Cell Therapy Technology
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Cell Therapy Technology Market
7. Market Analysis by Process
8. Market Analysis by Cell Type
9. Market Analysis by Product
10. Market Analysis by End user
11. Regional Market Analysis
12. North America Cell Therapy Technology Market
11. Europe Cell Therapy Technology Market
12. Asia PacificCell Therapy Technology Market
13. Latin America Cell Therapy Technology Market
14. MEACell Therapy Technology Market
15. Competitor Analysis
16. Company Profiles
17. Conclusion & Recommendations
Companies Mentioned
- Merck KGaA (Germany)
- STEMCELL Technologies (Canada)
- Miltenyi Biotec GmbH (Germany)
- Danaher Corporation (US)
- TrakCel (UK)
- FUJIFILM Irvine Scientific (US)
- Sartorius AG (Germany)
- Bio-Techne Corporation (US)
- Terumo BCT (US)
- Becton
- Dickinson and Company (US)
- MAK-SYSTEM (US)
- IxCells Biotechnology (China)
- Fresenius SE & Co. KGaA (Germany)
- Avantor Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- Corning Incorporated (US)
- Lonza Group (Switzerland)
- Werum IT Solutions GmbH (Germany)
- RoosterBio Inc. (US)
- SIRION Biotech GmbH (Germany)
- L7 Informatics Inc. (US)
- GPI Iberia (Spain)
- OrganaBio LLC (US)
- MaxCyte Inc. (US)
- Wilson Wolf Manufacturing Corporation (US)
For more information about this report visit https://www.researchandmarkets.com/r/y82l6u
